Comparison of SARC-F and Ishii score in screening for sarcopenia in older adults with type 2 diabetes mellitus: which screening tool should we use?

IF 0.7 4区医学 Q4 ENDOCRINOLOGY & METABOLISM International Journal of Diabetes in Developing Countries Pub Date : 2024-08-15 DOI:10.1007/s13410-024-01385-7

Yavuz Sultan Selim Akgul, Burcu Eren Cengiz, Gulsah Gunes Sahin, Derya Kocaslan, Neziha Ozlem Deveci, Sibel Akin

{"title":"Comparison of SARC-F and Ishii score in screening for sarcopenia in older adults with type 2 diabetes mellitus: which screening tool should we use?","authors":"Yavuz Sultan Selim Akgul, Burcu Eren Cengiz, Gulsah Gunes Sahin, Derya Kocaslan, Neziha Ozlem Deveci, Sibel Akin","doi":"10.1007/s13410-024-01385-7","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Sarcopenia is common in older adults, and type 2 diabetes mellitus (DM), highly prevalent in older adults, is a risk factor for sarcopenia. Early detection of sarcopenia is vital for the implementation of preventive and therapeutic measures.</p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>We aimed to compare the SARC-F questionnaire and Ishii score screening methods for sarcopenia in patients with type 2 DM.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>This cross-sectional study was conducted on 462 older adults with diabetes aged ≥ 60. Muscle mass and strength were assessed using the BIA device and handgrip dynamometer. Sarcopenia was defined in line with the European Sarcopenia Working Group 2 (EWGSOP2). The SARC-F questionnaire and Ishii score in screening for sarcopenia were compared.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The median age was 72 (67–76) for males and 68 (65–74) for females. The prevalence of sarcopenia based on the Ishii score, SARC-F, and EWGSOP2 was 28.4%, 40.9%, and 61.9%, respectively. The sensitivities of Ishii score and SARC-F in screening for sarcopenia were 84% and 47%, respectively. The Ishii score and SARCF specificities were 67% and 69%, respectively. PPV and NPV for the Ishii score were 79% and 45%, respectively. The PPV and NPV for the SARC-F were 71% and 55%, respectively. The AUC values of the Ishii score and SARC-F were 0.790 and 0.598, respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The Ishii score can be used in daily practice to screen for sarcopenia in older adults with type 2 DM.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":"41 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13410-024-01385-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Sarcopenia is common in older adults, and type 2 diabetes mellitus (DM), highly prevalent in older adults, is a risk factor for sarcopenia. Early detection of sarcopenia is vital for the implementation of preventive and therapeutic measures.

Objective

We aimed to compare the SARC-F questionnaire and Ishii score screening methods for sarcopenia in patients with type 2 DM.

Methods

This cross-sectional study was conducted on 462 older adults with diabetes aged ≥ 60. Muscle mass and strength were assessed using the BIA device and handgrip dynamometer. Sarcopenia was defined in line with the European Sarcopenia Working Group 2 (EWGSOP2). The SARC-F questionnaire and Ishii score in screening for sarcopenia were compared.

Results

The median age was 72 (67–76) for males and 68 (65–74) for females. The prevalence of sarcopenia based on the Ishii score, SARC-F, and EWGSOP2 was 28.4%, 40.9%, and 61.9%, respectively. The sensitivities of Ishii score and SARC-F in screening for sarcopenia were 84% and 47%, respectively. The Ishii score and SARCF specificities were 67% and 69%, respectively. PPV and NPV for the Ishii score were 79% and 45%, respectively. The PPV and NPV for the SARC-F were 71% and 55%, respectively. The AUC values of the Ishii score and SARC-F were 0.790 and 0.598, respectively.

Conclusion

The Ishii score can be used in daily practice to screen for sarcopenia in older adults with type 2 DM.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

比较 SARC-F 和 Ishii 评分在筛查 2 型糖尿病老年人肌肉疏松症中的应用：我们应该使用哪种筛查工具？

背景肌肉疏松症在老年人中很常见，而在老年人中发病率很高的 2 型糖尿病（DM）是导致肌肉疏松症的一个危险因素。我们旨在比较 SARC-F 问卷和 Ishii 评分筛查 2 型糖尿病患者肌肉疏松症的方法。方法这项横断面研究的对象是 462 名年龄≥ 60 岁的老年糖尿病患者。使用 BIA 设备和手握式测力计评估肌肉质量和力量。肌少症的定义与欧洲肌少症工作组 2 (EWGSOP2) 一致。结果男性的中位年龄为 72（67-76）岁，女性为 68（65-74）岁。根据 Ishii 评分、SARC-F 和 EWGSOP2，肌少症的患病率分别为 28.4%、40.9% 和 61.9%。石井氏评分和 SARC-F 对筛查肌少症的敏感度分别为 84% 和 47%。石井氏评分和 SARC-F 的特异性分别为 67% 和 69%。石井氏评分的 PPV 和 NPV 分别为 79% 和 45%。SARC-F 的 PPV 和 NPV 分别为 71% 和 55%。石井氏评分和 SARC-F 的 AUC 值分别为 0.790 和 0.598。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Journal of Diabetes in Developing Countries ENDOCRINOLOGY & METABOLISM-

CiteScore

1.60

自引率

0.00%

发文量

109

审稿时长

6 months

期刊介绍： International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.